HB-EGF has been reported to be upregulated in other cancer types such as breast and ovarian cancers and glioblastoma [33]–[35]; therefore, proHB-EGF may exert its functions in a broad range of cancer types. This evidence concerns the gene HBEGF and ovarian carcinoma.